| Dr James David Gottschall, MD | |
|
55 Fruit St, Boston, MA 02114-2621 | |
| (617) 359-7027 | |
| Not Available |
| Full Name | Dr James David Gottschall |
|---|---|
| Gender | Male |
| Speciality | Orthopaedic Surgery |
| Location | 55 Fruit St, Boston, Massachusetts |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144683194 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 268096 (Massachusetts) | Primary |
| Entity Name | Massachusetts General Physicians Organization Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801874573 PECOS PAC ID: 2466365820 Enrollment ID: O20031111000434 |
News Archive
"Swiss drug company Novartis AG and the Institute for OneWorld Health, a nonprofit group, will announce this week a partnership to discover drugs for a type of diarrhea that kills about 1.6 million children each year in the developing world," the Wall Street Journal reports.
The National Academy of Medicine along with the U.S. Food and Drug Administration's Center for Tobacco Products have named the 2017-2018 class of the FDA Tobacco Regulatory Science Fellows.
How do senior citizens perceive the importance of their oral health? The answer to that question might make all the difference whether they'll decide to seek treatment.
Dendreon Corporation today announced that the company has begun enrolling patients into a Phase 2 trial for DN24-02, Dendreon's investigational active cellular immunotherapy being evaluated for the treatment of HER2 positive cancer.
Commentators review the federal budget proposal announced Tuesday by House Budget Chairman Paul Ryan.
› Verified 5 days ago
| Entity Name | Signature Healthcare Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508804949 PECOS PAC ID: 7719876267 Enrollment ID: O20040312000372 |
News Archive
"Swiss drug company Novartis AG and the Institute for OneWorld Health, a nonprofit group, will announce this week a partnership to discover drugs for a type of diarrhea that kills about 1.6 million children each year in the developing world," the Wall Street Journal reports.
The National Academy of Medicine along with the U.S. Food and Drug Administration's Center for Tobacco Products have named the 2017-2018 class of the FDA Tobacco Regulatory Science Fellows.
How do senior citizens perceive the importance of their oral health? The answer to that question might make all the difference whether they'll decide to seek treatment.
Dendreon Corporation today announced that the company has begun enrolling patients into a Phase 2 trial for DN24-02, Dendreon's investigational active cellular immunotherapy being evaluated for the treatment of HER2 positive cancer.
Commentators review the federal budget proposal announced Tuesday by House Budget Chairman Paul Ryan.
› Verified 5 days ago
| Entity Name | The General Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023049236 PECOS PAC ID: 6507803806 Enrollment ID: O20080313000351 |
News Archive
"Swiss drug company Novartis AG and the Institute for OneWorld Health, a nonprofit group, will announce this week a partnership to discover drugs for a type of diarrhea that kills about 1.6 million children each year in the developing world," the Wall Street Journal reports.
The National Academy of Medicine along with the U.S. Food and Drug Administration's Center for Tobacco Products have named the 2017-2018 class of the FDA Tobacco Regulatory Science Fellows.
How do senior citizens perceive the importance of their oral health? The answer to that question might make all the difference whether they'll decide to seek treatment.
Dendreon Corporation today announced that the company has begun enrolling patients into a Phase 2 trial for DN24-02, Dendreon's investigational active cellular immunotherapy being evaluated for the treatment of HER2 positive cancer.
Commentators review the federal budget proposal announced Tuesday by House Budget Chairman Paul Ryan.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr James David Gottschall, MD 55 Fruit St, Boston, MA 02114-2621 Ph: (617) 726-7500 | Dr James David Gottschall, MD 55 Fruit St, Boston, MA 02114-2621 Ph: (617) 359-7027 |
News Archive
"Swiss drug company Novartis AG and the Institute for OneWorld Health, a nonprofit group, will announce this week a partnership to discover drugs for a type of diarrhea that kills about 1.6 million children each year in the developing world," the Wall Street Journal reports.
The National Academy of Medicine along with the U.S. Food and Drug Administration's Center for Tobacco Products have named the 2017-2018 class of the FDA Tobacco Regulatory Science Fellows.
How do senior citizens perceive the importance of their oral health? The answer to that question might make all the difference whether they'll decide to seek treatment.
Dendreon Corporation today announced that the company has begun enrolling patients into a Phase 2 trial for DN24-02, Dendreon's investigational active cellular immunotherapy being evaluated for the treatment of HER2 positive cancer.
Commentators review the federal budget proposal announced Tuesday by House Budget Chairman Paul Ryan.
› Verified 5 days ago
Kiran J Agarwal-harding, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: Massachusetts General Hospital, 55 Fruit St., Boston, MA 02114 Phone: 617-726-2942 | |
Dr. Adam Stephen Olsen, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 75 Francis St, Boston, MA 02115 Phone: 617-732-5655 | |
Dr. Bertram Zarins, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 175 Cambridge St, Suite 400, Boston, MA 02114 Phone: 617-726-3421 Fax: 617-726-3438 | |
Andrew P White, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 330 Brookline Ave, Stoneman 10, Boston, MA 02215 Phone: 617-667-3940 | |
Ruth A Delaney, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 Phone: 617-726-2800 | |
Michael Douglas Baratz, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 800 Washington St, Boston, MA 02111 Phone: 617-636-5000 Fax: 617-636-1465 | |
Sarah Stelma, Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 800 Washington St, Tmc Box 306, Boston, MA 02111 Phone: 617-636-5172 |